Mitchell S. Abrahamsen

Mitchell S. Abrahamsen

Auto-generated profile, based on publicly available information

Mitchell S. Abrahamsen

Veterinary and Biomedical Sciences, University of Minnesota, St Paul, MN 55108, USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2004 in Science
Verified
Journal Article
Closed access
PDF file
MAMitchell S. Abrahamsen
Mitchell S. Abrahamsen
TTThomas J. Templeton
Thomas J. Templeton
SEShinichiro Enomoto
Shinichiro Enomoto
JAJuan Abrahante
Juan Abrahante
GZGuan Zhu
Guan Zhu
VKVivek Kapur
Vivek Kapur
The apicomplexan Cryptosporidium parvum is an intestinal parasite that affects healthy humans and animals, and causes an unrelenting infection in immunocompromised individuals such as AIDS patients. We report the complete genome sequence of C. parvum , type II isolate. Genome analysis identifies extremely streamlined metabolic pathways and a reliance on the host for nutrients. In contrast to Plasmodium and Toxoplasma , the parasite lacks an apicoplast and its genome, and possesses a degenerate mitochondrion that has lost its genome. Several novel classes of cell-surface and secreted proteins with a potential role in host interactions and pathogenesis were also detected. Elucidation of the core metabolism, including enzymes with high similarities to bacterial and plant counterparts, opens new avenues for drug development.

19 October 2004 in Genome Biology
Verified
Journal Article
Open access
PDF file
JHJinling Huang
Jinling Huang
NMNandita Mullapudi
Nandita Mullapudi
CLCheryl A Lancto
Cheryl A Lancto
MSMarla Scott
Marla Scott
MAMitchell S Abrahamsen
Mitchell S Abrahamsen
JKJessica C Kissinger
Jessica C Kissinger
Background: The apicomplexan parasite Cryptosporidium parvum is an emerging pathogen capable of causing illness in humans and other animals and death in immunocompromised individuals. No effective treatment is available and the genome sequence has recently been completed. This parasite differs from other apicomplexans in its lack of a plastid organelle, the apicoplast. Gene transfer, either intracellular from an endosymbiont/donor organelle or horizontal from another organism, can provide evidence of a previous endosymbiotic relationship and/or alter the genetic repertoire of the host organism. Given the importance of gene transfers in eukaryotic evolution and the potential implications for chemotherapy, it is important to identify the complement of transferred genes in Cryptosporidium. Results: We have identified 31 genes of likely plastid/endosymbiont (n = 7) or prokaryotic (n = 24) origin using a phylogenomic approach. The findings support the hypothesis that Cryptosporidium evolved from a plastid-containing lineage and subsequently lost its apicoplast during evolution. Expression analyses of candidate genes of algal and eubacterial origin show that these genes are expressed and developmentally regulated during the life cycle of C. parvum. Conclusions: Cryptosporidium is the recipient of a large number of transferred genes, many of which are not shared by other apicomplexan parasites. Genes transferred from distant phylogenetic sources, such as eubacteria, may be potential targets for therapeutic drugs owing to their phylogenetic distance or the lack of homologs in the host. The successful integration and expression of the transferred genes in this genome has changed the genetic and metabolic repertoire of the parasite.

1 February 2004 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
TTThomas J. Templeton
Thomas J. Templeton
CLCheryl A. Lancto
Cheryl A. Lancto
VVVladimir Vigdorovich
Vladimir Vigdorovich
CLChang Liu
Chang Liu
NLNicole R. London
Nicole R. London
MAMitchell S. Abrahamsen
Mitchell S. Abrahamsen
Coccidian parasites are transmitted via a fecal oocyst stage that is exceptionally resistant to environmental stress and harsh chemical treatments, which allows parasites to stably persist outside a host. Because of its oocyst durability Cryptosporidium parvum is a significant water- and food-borne pathogen of humans, as well as animals of agricultural importance. To date, only one apicomplexan oocyst membrane protein has been identified, Cryptosporidium oocyst wall protein 1 (COWP1). COWP1 has a highly cysteine-rich periodicity due to arrays of two apicomplexan-specific motifs, designated the type I and type II domains. In this study, exhaustive BLAST screening of a complete C. parvum genome sequence database resulted in identification of eight additional genes encoding similar arrays of cysteine-rich type I and/or type II domains. Transcript expression analysis revealed that all COWP genes are abundantly expressed at a time when developing oocysts are observed, roughly 48 to 72 h after inoculation of in vitro cultures. A monoclonal antibody recognizing COWP8 specifically localized to the C. parvum oocyst wall, supporting the hypothesis that multiple COWPs play a role in the oocyst wall structure. BLAST screening of the Toxoplasma gondii genome sequence database resulted in identification of a gene encoding at least one COWP homolog ( Tg OWP1), and this multiexon sequence information was used to isolate a full-length cDNA. Exhaustive screening of Plasmodium sp. genome sequence databases by using COWP genes as BLAST queries failed to detect similar proteins in Plasmodium . We therefore propose that the COWP family of proteins have a structural role in apicomplexan species that produce durable shed cysts capable of surviving environmental stress.

1 December 2002 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
MDMingqi Deng
Mingqi Deng
TTThomas J. Templeton
Thomas J. Templeton
NLNicole R. London
Nicole R. London
CBCarrey Bauer
Carrey Bauer
ASAlison A. Schroeder
Alison A. Schroeder
MAMitchell S. Abrahamsen
Mitchell S. Abrahamsen
Cryptosporidium parvum is recognized as an enteropathogen of great worldwide medical and veterinary importance, yet understanding of its pathogenesis has been hampered in part by limited knowledge of the invasion machinery of this parasite. Recently, genes containing thrombospondin type 1 (TSP1) domains have been identified in several genera of apicomplexans, including thrombospondin-related adhesive proteins (TRAPs) that have been implicated as key molecules for parasite motility and adhesion onto host cell surfaces. Previously, a large-scale random survey of the C. parvum genome conducted in our laboratory revealed the presence of multiple genomic DNA sequences with a high degree of similarity to known apicomplexan TRAP genes. In the present study, TBLASTN screening of available C. parvum genomic sequences by using TSP1 domains as queries identified a total of 12 genes possessing TSP1-like domains. All genes have putative signal peptide sequences, one or more TSP1-like domains, plus additional extracellular protein modules such as Kringle, epidermal growth factor, and Apple domains. Two genes, putative paralogs Cp TSP8 and Cp TSP9, contain predicted introns near their amino termini, which were verified by comparing PCR products from cDNA versus genomic DNA templates. Reverse transcription-PCR analysis of transcript levels reveals that C. parvum TSP genes were developmentally regulated with distinct patterns of expression during in vitro infection. TRAPC1, Cp TSP3, and Cp TSP11 were expressed at high levels during both early and late stages of infection, whereas Cp TSP2, Cp TSP5, Cp TSP6, Cp TSP8, and Cp TSP9 were maximally expressed during the late stages of infection. Only Cp TSP4 was highly expressed solely at an early stage of infection.

9 January 2007 in BMC Genomics
Verified
Journal Article
Open access
NMNandita Mullapudi
Nandita Mullapudi
CLCheryl A Lancto
Cheryl A Lancto
MAMitchell S Abrahamsen
Mitchell S Abrahamsen
JKJessica C Kissinger
Jessica C Kissinger
Cryptosporidium parvum is a unicellular eukaryote in the phylum Apicomplexa. It is an obligate intracellular parasite that causes diarrhea and is a significant AIDS-related pathogen. Cryptosporidium parvum is not amenable to long-term laboratory cultivation or classical molecular genetic analysis. The parasite exhibits a complex life cycle, a broad host range, and fundamental mechanisms of gene regulation remain unknown. We have used data from the recently sequenced genome of this organism to uncover clues about gene regulation in C. parvum. We have applied two pattern finding algorithms MEME and AlignACE to identify conserved, over-represented motifs in the 5' upstream regions of genes in C. parvum. To support our findings, we have established comparative real-time -PCR expression profiles for the groups of genes examined computationally. We find that groups of genes that share a function or belong to a common pathway share upstream motifs. Different motifs are conserved upstream of different groups of genes. Comparative real-time PCR studies show co-expression of genes within each group (in sub-sets) during the life cycle of the parasite, suggesting co-regulation of these genes may be driven by the use of conserved upstream motifs. This is one of the first attempts to characterize cis-regulatory elements in the absence of any previously characterized elements and with very limited expression data (seven genes only). Using de novo pattern finding algorithms, we have identified specific DNA motifs that are conserved upstream of genes belonging to the same metabolic pathway or gene family. We have demonstrated the co-expression of these genes (often in subsets) using comparative real-time-PCR experiments thus establishing evidence for these conserved motifs as putative cis-regulatory elements. Given the lack of prior information concerning expression patterns and organization of promoters in C. parvum we present one of the first investigations of gene regulation in this important human pathogen.

1 September 1996 in Journal of Eukaryotic Microbiology
Verified
Journal Article
Closed access
PDF file
MAMitchell S. Abrahamsen
Mitchell S. Abrahamsen
ASAlison A. Schroeder
Alison A. Schroeder
CLCheryl A. Lancto
Cheryl A. Lancto